Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 33%
Hold 47%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is a global leader in the medical technology industry, with a diverse portfolio of products and solutions. Its strong focus on innovation and strategic growth initiatives, such as acquisitions and R&D investments, position the company for future success. Additionally, GEHC's commitment to increasing margins and driving recurring revenue through services and pharmaceutical products bodes well for its financial outlook. While competition and regulatory compliance remain challenges, the company is actively addressing these issues and has a positive long-term outlook.

Bears say

GE HealthCare Techs is heavily reliant on their imaging segment, which accounts for almost half of their revenue, while other important segments, such as advanced visualization solutions and patient care solutions, only account for around 40%. Additionally, the company's reliance on the US market leaves them vulnerable to any changes in healthcare policies, and their recurring revenue only makes up about half of their total revenue, which could impact their stability and growth potential in the future. Furthermore, with potential risks related to manufacturing, supply chain, and regulatory issues, there are significant uncertainties surrounding the company's ability to maintain its current market position and continue to innovate and compete in the highly competitive medical technology industry.

GEHC has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 33% recommend Buy, 47% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 15 analysts, GEHC has a Buy consensus rating as of Jul 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.